Pharmacies continue to be a highly desired asset among net lease investors. With CVS & Walgreens leading the way, cap rates for pharmacies continues to compress. The investment grade credit of premier tenants (Walgreens and CVS), long leases and quality real estate makes pharmacies an ideal investment option. As such, cap rates are lower than the net lease retail average. A lack of new supply in the market has also affected pharmacies with investors willing to pay premiums for a dwindling pool of assets.
Though there has been some talk of increasing interest rates forcing cap rates upward – the reality is cap rates have continued to compress. Though interest rates are incrementally rising - they still remain at historic lows compared to the previous market high in 2006. As a result, it still makes sense for transactions to trade at bold low rates.
Among Walgreens and CVS transactions themselves, we can see a definite preference for long leases – 15 years or more. These investments on average demanded much lower cap rates – with average Walgreens cap rates at 6.17% compared to 5.76% for deals with 15+ years on the lease. CVS transactions saw similar cap rate spreads – a 6.30% average compared to 5.88% for 15+ plus years on the lease. In today's market risk adverse properties still demand a premium from investors.
View the Full Report
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.